Approval · Notice of Compliance 20665 · 2018
MEMANTINE: Notice of Compliance 20665
Issued March 26, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20665
- Date
- March 26, 2018
- Company
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Licensing agreeement between two companies
- Canadian reference product
- EBIXA (Lundbeck Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MEMANTINE | 02446049 | Marketed |
Medicinal ingredients
- MEMANTINE HYDROCHLORIDE 10 MG per TAB